Cancer is a severe disease that affects millions of people around the world. Some types of cancer, like blood cancers, can be hard to treat with regular methods such as chemotherapy or radiation. But there is a new, powerful way to fight cancer — CAR T-cell therapy.
CAR T-cell therapy is a special kind of immunotherapy. It uses the patient's own immune cells to find and kill cancer cells. This treatment has shown excellent results in patients with certain blood cancers.
India is now offering CAR T-cell therapy at a much lower cost than many Western countries. The cost of CAR T-cell therapy in India lies between USD 45,000 to USD 60,000. Indian hospitals offer skilled doctors, advanced laboratories, and robust support services for international patients. That's why an increasing number of people from abroad are choosing India for this treatment.
CAR T-cell therapy stands for Chimeric Antigen Receptor T-cell therapy. It is a type of immunotherapy. That means it helps your body's own immune system fight cancer.
In this treatment, doctors take T-cells (a type of white blood cell) from your blood. These T-cells are changed in a lab. The change allows them to find better and kill cancer cells. The new, powerful cells are then put back into your body to attack the cancer.
This method differs significantly from chemotherapy or radiation. Instead of killing healthy cells, it targets only the cancer cells. That's why it's often used when other treatments don't work or when cancer comes back.
The complete CAR T-cell therapy process takes several weeks. It happens in stages. Here is a simple step-by-step guide to how it works:
CAR T-cell therapy is most effective for certain types of blood cancer. It is mainly used when the cancer has come back (relapsed) or has not responded to other treatments.
Doctors in India may recommend CAR T-cell therapy only after checking your medical history, reports, and type of cancer. It is not suitable for all patients.
India took a significant step forward in cancer care with the launch of NexCAR19, the country's first homegrown CAR T-cell therapy. It was developed by ImmunoACT, a company incubated at IIT Bombay, in partnership with Tata Memorial Centre and Apollo Hospitals.
NexCAR19 is designed to treat B-cell cancers, especially B-cell acute lymphoblastic leukemia (ALL) and B-cell non-Hodgkin lymphoma. These are the same types of blood cancers treated with CAR T-cell therapy in the USA.
Many international patients are choosing India for CAR T-cell therapy for several reasons:
CAR T-cell therapy is one of the most advanced cancer treatments available today. Because it involves lab-engineered immune cells, the process is complex and expensive. However, in India, this treatment is far more affordable than in the United States or Europe. The average CAR T-cell Therapy Cost in India is USD 45,000 to USD 60,000 (INR 30 to INR 50 lakhs), depending on the type of cancer, hospital, and treatment plan.
This is significantly less than the cost in Western countries, where it can exceed USD 500,000 or more. India has recently developed indigenous CAR T-cell products, which have further reduced the price.
Before choosing a hospital, it's essential to know what's included in the treatment package. Most hospitals in India offer precise and complete cost estimates. It helps international patients budget their trips and avoid surprise charges. Here's a list of what's usually included and what's not.
Before starting, the hospital will provide a detailed cost estimate with a breakdown of what is included. Always ask for this information before planning your trip.
The cost of CAR T-cell Therapy can vary depending on several personal and medical factors. Knowing these in advance helps patients plan better. From the type of cancer to hospital stay, each factor adds to the final cost. Let's explore the most common reasons for cost changes.
CAR T-cell therapy doesn't happen in one day. It takes several weeks to complete, as the cells need to be collected, engineered, and then infused. Here's a simple breakdown of the entire process, from start to recovery.
| Stage | Time Duration |
|---|---|
| Medical Evaluation & Tests | 3–5 days |
| T-cell Collection (Leukapheresis) | 1 day |
| Cell Engineering in Lab | 2–3 weeks |
| Conditioning Chemotherapy | 3–4 days |
| CAR T-Cell Infusion | 1 day |
| Hospital Monitoring | 7–14 days (or more) |
| Discharge & Rest | 7–10 days (nearby stay) |
The total duration from start to finish is 6 to 8 weeks (depending on the patient's condition and hospital protocol).
Recovery is a crucial component of the CAR T-cell therapy journey. After the cells are infused into your body, doctors will monitor you closely. It helps ensure the treatment works well and catches any early side effects. Most patients require hospitalization for a few weeks after the infusion.
Here is what to expect during the recovery phase:
CAR T-cell therapy is a powerful and promising treatment for certain types of blood cancer. It works in a completely different way compared to chemotherapy or radiation. But, like any advanced therapy, it comes with both benefits and risks. Let's understand both clearly.
CAR T-cell therapy has shown success, whereas other treatments have failed. It is beneficial for patients whose cancer has returned after treatment or did not respond to standard care. Here are the main benefits:
While the therapy can be life-saving, it also comes with some risks. These side effects are usually manageable in experienced hospitals, such as those in India. Here are the main risks:
India is becoming a trusted destination for advanced cancer care, including CAR T-cell therapy. The country offers the same treatment available in the USA or UK—at a much lower cost. Indian hospitals, such as our specialized institute, are renowned for their experienced doctors, state-of-the-art facilities, and patient-centered care. Here are the top reasons international patients choose India:
Traveling to another country for treatment can feel overwhelming. That's why Indian hospitals provide complete support services to make your journey effortless and stress-free. Here's what you can expect:
Tip: Choose a hospital with an International Patient Department. They will take care of everything — so you can focus on getting better.
Patients with certain blood cancers, such as leukemia or lymphoma, may qualify. Doctors will review your reports to determine if you're suitable for this treatment.
The total stay in India for CAR T-cell therapy typically ranges from 6 to 8 weeks, including evaluation, treatment, and recovery monitoring.
Yes, when performed in experienced centers with proper monitoring, CAR T-cell therapy is safe. Side effects are manageable with timely medical intervention.
Yes, CAR T-cell therapy is approved for pediatric patients with certain conditions like acute lymphoblastic leukemia (ALL) and is available in specialized centers in India.
CAR T-cell therapy has shown high success rates, with many patients achieving complete remission even after other treatments have failed, particularly for B-cell cancers.
Unlike chemotherapy which attacks all rapidly dividing cells, CAR T-cell therapy specifically targets cancer cells using engineered immune cells, leading to more precise treatment with fewer side effects on healthy tissues.
Common side effects include cytokine release syndrome (fever, low blood pressure), neurological symptoms (confusion, headache), fatigue, and increased infection risk. These are managed with appropriate medical care.
CAR T-cell therapy can lead to long-term remission and is considered curative for some patients, especially those with certain blood cancers who haven't responded to other treatments.